4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001415889-25-002263
Director sold 3,000 shares at $4.65 ($13,935)
- Director acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2025-01-27 | Option exercise 10b5-1 | +3,000 | $2.93 | $8,796 | 144,950 | D |
| Johnston John Joseph Director | 2025-01-27 | Sale 10b5-1 | −3,000 | $4.65 | $13,935 | 141,950 | D |
| Derivatives | |||||||
| Johnston John Joseph Director | 2025-01-27 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 17,417 | D | ||
| Open-market sales · 3,000 sh · avg $4.65 · $13,935 | |||||||
Loading xslF345X05/form4-01292025_090107.xml…